Expression of tumour necrosis factor receptors (CD120a and CD120b) on bronchoalveolar cells

Cytokine

Volumn 11, Issue 8, 1999, Pages 611-616

  Fitschen, J örn ^a   Ernst, Martin ^a   Martinet, Nadine ^b   Schlaak, Max ^c   Müller Quernheim, Joachim ^c  

^a RESEARCH CENTER BORSTEL   (Germany)

^b INSERM   (France)

^c NONE

Author keywords

BAL cells; CD120; Lung; Tumour necrosis factor receptor expression

Indexed keywords

LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GRANULOCYTE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 0033178383     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0469     Document Type: Article

References (35)

1. Beutler B., Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. A Rev Immunol. 7:1989;625-655.
2. Vilcek J., Lee T.H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 266:1991;7313-7316.
3. Sung S.S., Bjorndahl J.M., Wang C.Y., Kao H.T., Fu S.M. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med. 167:1988;937-953.
4. Old L.J. Tumor necrosis factor (TNF). Science. 230:1985;630-632.
5. Amino N., Linn E.S., Pysher T.J., Mier R., Moore G.E., DeGroot L.J. Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin. J Immunol. 113:1974;1334-1345.
6. Dembic Z., Loetscher H., Gubler U., Pan Y.C., Lahm H.W., Gentz R., Brockhaus M., Lesslauer W. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine. 2:1990;231-237.
7. Loetscher H., Pan Y.C., Lahm H.W., Gentz R., Brockhaus M., Tabuchi H., Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:1990;351-359.
8. Schall T.J., Lewis M., Koller K.J., Lee A., Rice G.C., Wong G.H., Gatanaga T., Granger G.A., Lentz R., Raab H. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:1990;361-370.
9. Smith, CA, Davis, T, Anderson, D, Solam, L, Beckmann, MP, Jerzy, R, Dower, SK, Cosman, D, Goodwin, RG, 1990, A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins, Science, 248:1019-1023.
10. Nicod L.P., Galve de Rochemonteix B., Dayer J.M. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann NY Acad Sci. 725:1994;323-330.
11. Porteu F., Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med. 172:1990;599-607.
12. Porteu F., Brockhaus M., Wallach D., Engelmann H., Nathan C.F. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J Biol Chem. 266:1991;18846-18853.
13. Olsson I., Lantz M., Nilsson E., Peetre C., Thysell H., Grubb A., Adolf G. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol. 42:1989;270-275.
14. Aderka D., Engelmann H., Shemer-Avni Y., Hornik V., Galil A., Sarov B., Wallach D. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res11. 1992;157-159.
15. Andus T., Gross V., Holstege A., Ott M., Weber M., David M., Gallati H., Gerok W., Scholmerich J. High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology. 16:1992;749-755.
16. Hino T., Nakamura H., Shibata Y., Abe S., Kato S., Tomoike H. Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis. Lung. 175:1997;187-193.
17. Aderka D., Wysenbeek A., Engelmann H., Cope A.P., Brennan F., Molad Y., Hornik V., Levo Y., Maini R.N., Feldmann M. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum. 36:1993;1111-1120.
18. Humbert M., Roux-Lombard P., Cerrina J., Magnan A., Simonneau G., Dartevelle P., Galanaud P., Dayer J.M., Emilie D. Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitis. Am J Respir Crit Care Med. 149:1994;1681-1685.
19. Brockhaus M., Schoenfeld H.J., Schlaeger E.J., Hunziker W., Lesslauer W., Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA. 87:1990;3127-3131.
20. Lindvall L., Lantz M., Gullberg U., Olsson I. Modulation of the constitutive gene expression of the 55 kD tumor necrosis factor receptor in hematopoietic cells. Biochem Biophys Res Commun. 172:1990;557-563.
21. Ryffel B., Brockhaus M., Greiner B., Mihatsch M.J., Gudat F. Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology. 74:1991;446-452.
22. Shimomoto H., Hasegawa Y., Nozaki Y., Takagi N., Shibagaki T., Nakao A., Shimokata K. Expression of tumor necrosis factor receptors in human lung cancer cells and normal lung tissues. Am J Respir Cell Mol Biol. 13:1995;271-278.
23. Galve de Rochemonteix B., Nicod L.P., Dayer J.M. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma. Am J Respir Cell Mol Biol. 14:1996;279-287.
24. Agostini C., Zambello R., Sancetta R., Cerutti A., Milani A., Tassinari C., Facco M., Cipriani A., Trentin L., Semenzato G. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med. 153:1996;1359-1367.
25. Nakamura H., Hino T., Kato S., Shibata Y., Takahashi H., Tomoike H. Tumour necrosis factor receptor gene expression and shedding in human whole lung tissue and pulmonary epithelium. Eur Respir J. 9:1996;1643-1647.
26. Agostini C., Zambello R., Trentin L., Cerutti A., Enthammer C., Facco M., Milani A., Sancetta R., Garbisa S., Semenzato G. Expression of TNF receptors by T cells and membrane TNF-alpha by alveolar macrophages suggests a role for TNF-alpha in the regulation of the local immune responses in the lung of HIV-1-infected patients. J Immunol. 154:1995;2928-2938.
27. Joyce D.A., Steer J.H. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes. J Interferon Cytokine Res. 15:1995;947-954.
28. Owen-Schaub L.B., Crump W.L.D., Morin G.I., Grimm E.A. Regulation of lymphocyte tumor necrosis factor receptors by IL-2. J Immunol. 143:1989;2236-2241.
29. Aggarwal B.B., Eessalu T.E., Hass P.E. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature. 318:1985;665-667.
30. Hohmann H.P., Brockhaus M., Baeuerle P.A., Remy R., Kolbeck R., van Loon A.P. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. J Biol Chem. 265:1990;22409-22417.
31. Homolka J., Muller-Quernheim J. Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung. 171:1993;173-183.
32. Hunninghake G.W., Crystal R.G. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 305:1981;429-434.
33. Martinet N., Charles T., Vaillant P., Vignaud J.M., Lambert J., Martinet Y. Characterization of a tumor necrosis factor-alpha inhibitor activity in cancer patients. Am J Respir Cell Mol Biol. 6:1992;510-515.
34. Seckinger P., Isaaz S., Dayer J.M. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem. 264:1989;11966-11973.
35. Ernst M., Kern P., Flad H-D, Ulmer A.J. Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with aquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC). J Clin Immunol. 6:1986;170-181.